GMP-Grade Manufacturing and Quality Control of a Non-Virally Engineered Advanced Therapy Medicinal Product for Personalized Treatment of Age-Related Macular Degeneration
Biomedicines, vol. 10, pp. 2777
Abstract
The introduction of new therapeutics requires validation of Good Manufacturing Practice (GMP)-grade manufacturing including suitable quality controls. This is challenging for Advanced Therapy Medicinal Products (ATMP) with personalized batches. We have developed a person-alized, cell-based gene therapy to treat age-related macular degeneration and established a vali-dation strategy of the GMP-grade manufacture for the ATMP; manufacturing and quality control were challenging due to a low cell number, batch-to-batch variability and short production duration. Instead of patient iris pigment epithelial cells, human donor tissue was used to produce the transfected cell product ("tIPE"). We implemented an extended validation of 104 tIPE productions. Procedure, operators and devices have been validated and qualified by determining cell number, viability, extracellular DNA, sterility, duration, temperature and volume. Transfected autologous cells were transplanted to rabbits verifying feasibility of the treatment. A container has been engineered to ensure a safe transport from the production to the surgery site. Criteria for successful validation and qualification were based on tIPE's Critical Quality Attributes and Process Parameters, its manufacture and release criteria. The validated process and qualified operators are essential to bring the ATMP into clinic and offer a general strategy for the transfer to other manufacture centers and personalized ATMPs.
Authors 13
-
Martina Kropp corresponding
University of Geneva · University Hospital of Geneva
Affiliation as printed
Department of Ophthalmology, University Hospitals of Geneva, 1205 Geneva, Switzerland
Group of Experimental Ophthalmology, University of Geneva, 1205 Geneva, Switzerland
-
University of Geneva · University Hospital of Geneva
Affiliation as printed
Department of Ophthalmology, University Hospitals of Geneva, 1205 Geneva, Switzerland
Group of Experimental Ophthalmology, University of Geneva, 1205 Geneva, Switzerland
-
University of Geneva · University Hospital of Geneva
Affiliation as printed
Department of Ophthalmology, University Hospitals of Geneva, 1205 Geneva, Switzerland
Group of Experimental Ophthalmology, University of Geneva, 1205 Geneva, Switzerland
-
RWTH Aachen University · Universitätsklinikum Aachen
Affiliation as printed
Department of Ophthalmology, University Hospital RWTH Aachen, 52074 Aachen, Germany
-
University of Geneva · University Hospital of Geneva
Affiliation as printed
Department of Ophthalmology, University Hospitals of Geneva, 1205 Geneva, Switzerland
Group of Experimental Ophthalmology, University of Geneva, 1205 Geneva, Switzerland
-
Affiliation as printed
BVI c/o Optikon 2000 S.p.A., 00138 Rome, Italy
-
Affiliation as printed
IGEA S.p.A., 41012 Carpi, Italy
-
Affiliation as printed
BioAir S.p.A., 20016 Pero, Italy
-
Centre National de la Recherche Scientifique · Inserm · Université Paris Cité · Unité de Technologies Chimiques et Biologiques pour la Santé
Affiliation as printed
CNRS, Inserm, UTCBS, Université Paris Cité, F-75006 Paris, France
-
Affiliation as printed
Division of Medical Biotechnology, Paul-Ehrlich-Institute, 63225 Langen, Germany
-
Centre National de la Recherche Scientifique · Université Paris Sciences et Lettres · Inserm · Université Paris Cité · Chimie ParisTech - PSL · Unité de Technologies Chimiques et Biologiques pour la Santé
Affiliation as printed
CNRS, Inserm, UTCBS, Université Paris Cité, F-75006 Paris, France
Chimie ParisTech, PSL Research University, F-75005 Paris, France
-
Affiliation as printed
Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany
-
Gabriele Thumann corresponding
University of Geneva · University Hospital of Geneva
Affiliation as printed
Department of Ophthalmology, University Hospitals of Geneva, 1205 Geneva, Switzerland
Group of Experimental Ophthalmology, University of Geneva, 1205 Geneva, Switzerland
Cited by 13 stored of 13
13 results
No patents citing this paper on Lens.org (checked 2026-10-06).
References 41
-
W1571229160details pending0citations
-
W1991618236details pending0citations
-
W2036173439details pending0citations
-
W2084177945details pending0citations
-
W2129042241details pending0citations
-
W2141614415details pending0citations
-
W2154500423details pending0citations
-
W2164618384details pending0citations
-
W2215470046details pending0citations
-
W2411159809details pending0citations
-
W2586325633details pending0citations
-
W2601350462details pending0citations
-
W2744097363details pending0citations
-
W2777365399details pending0citations
-
W2788503277details pending0citations
-
W2793222899details pending0citations